Abstract
Background
Chronic enteropathy associated with the SLCO2A1 gene (CEAS) is an enteropathy characterized by multiple small intestinal ulcers of nonspecific histology, also known as chronic nonspecific multiple ulcers of the small intestine. The SLCO2A1 gene encodes a prostaglandin transporter (PGT).
Aims
The aim of this study was to investigate the clinical characteristics of ten Chinese patients with intestinal ulcers of unknown origin, screen them for variants of SLCO2A1, and to investigate the expression of PGT in the small intestinal mucosa of patients with CEAS.
Methods
Ten Chinese patients with intestinal ulcers of unknown origin were included in this study. Blood samples were collected for whole-exome sequencing and Sanger sequencing of candidate gene variants. Immunohistochemical staining was used to investigate the expression of PGT.
Results
These ten patients were clinically diagnosed with intestinal ulcers of unknown origin based on criteria established according to earlier publications. Three of them were genetically diagnosed as having CEAS and four candidate variants of the SLCO2A1 gene were identified, among which c.941-1G>A, c.178G>A and c.1681C>T were detected in patients with CEAS for the first time. The terminal ileum was involved in all three patients with CEAS in our study, which was different from the results of Japanese patients. The expression of PGT in the vascular endothelial cells of the intestinal mucosa tissues of patients with CEAS was negative or intermediate.
Conclusion
We summarized the clinical data of ten Chinese patients with intestinal ulcers of unknown origin and identified three novel SLCO2A1 variants from three patients with CEAS. This study improves our understanding of CEAS and broadens the spectrum of SLCO2A1 variants known to cause CEAS.
Similar content being viewed by others
References
Mazal J. Crohn disease: pathophysiology, diagnosis, and treatment. Radiol. Technol.. 2014;85:297–316.
Tsibouris P, Kalantzis C, Apostolopoulos P et al. Small bowel ulcerative lesions are common in elderly NSAIDs users with peptic ulcer bleeding. World J. Gastrointest. Endosc.. 2014;6:612–619. https://doi.org/10.4253/wjge.v6.i12.612.
Wilson IR, Cooley NV, Luibel FJ. Nonspecific stenosing small bowel ulcers. Experience in one California county. Am. J. Gastroenterol.. 1968;50:449–455.
Matsumoto T, Nakamura S, Esaki M et al. Endoscopic features of chronic nonspecific multiple ulcers of the small intestine: comparison with nonsteroidal anti-inflammatory drug-induced enteropathy. Dig. Dis. Sci.. 2006;51:1357–1363. https://doi.org/10.1007/s10620-006-9080-x.
Adler DH, Cogan JD, Phillips JA et al. Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction. J. Clin. Investig.. 2008;118:2121–2131. https://doi.org/10.1172/jci30473.
Esaki M, Umeno J, Kitazono T, Matsumoto T. Clinicopathologic features of chronic nonspecific multiple ulcers of the small intestine. Clin. J. Gastroenterol.. 2015;8:57–62. https://doi.org/10.1007/s12328-015-0559-x.
Umeno J, Hisamatsu T, Esaki M et al. A Hereditary Enteropathy Caused by Mutations in the SLCO2A1 Gene, Encoding a Prostaglandin Transporter. PLoS Genet. 2015;11:e1005581. https://doi.org/10.1371/journal.pgen.1005581.
Kanai N, Lu R, Satriano JA, Bao Y, Wolkoff AW, Schuster VL. Identification and characterization of a prostaglandin transporter. Science. 1995;268:866–869.
Seifert W, Kuhnisch J, Tuysuz B, Specker C, Brouwers A, Horn D. Mutations in the prostaglandin transporter encoding gene SLCO2A1 cause primary hypertrophic osteoarthropathy and isolated digital clubbing. Hum Mutat. 2012;33:660–664. https://doi.org/10.1002/humu.22042.
Zhang Z, Xia W, He J et al. Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy. Am. J. Hum. Genet.. 2012;90:125–132. https://doi.org/10.1016/j.ajhg.2011.11.019.
Diggle CP, Parry DA, Logan CV et al. Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis. Hum Mutat. 2012;33:1175–1181. https://doi.org/10.1002/humu.22111.
Umeno J, Esaki M, Hirano A et al. Clinical features of chronic enteropathy associated with SLCO2A1 gene: a new entity clinically distinct from Crohn's disease. J. Gastroenterol.. 2018. https://doi.org/10.1007/s00535-017-1426-y.
13. Brooke MA, Longhurst HJ, Plagnol V et al. Cryptogenic multifocal ulcerating stenosing enteritis associated with homozygous deletion mutations in cytosolic phospholipase A2-alpha. Gut. 2014;63:96-104. doi:10.1136/gutjnl-2012-303581.
Tay A, Simon JS, Squire J, Hamel K, Jacob HJ, Skorecki K. Cytosolic phospholipase A2 gene in human and rat: chromosomal localization and polymorphic markers. Genomics. 1995;26:138–141.
Sun X, Hosoe N, Miyanaga R et al. A male Korean who was diagnosed with chronic enteropathy associated with SLCO2A1 (CEAS): case report with literature review. BMJ Open Gastroenterol. 2018;5:e000223. https://doi.org/10.1136/bmjgast-2018-000223.
Hu P, He H, Dai N, Zhang S, Deng L. Chronic enteropathy associated with SLCO2A1 gene: A case report and literature review. Clin. Res. Hepatol. Gastroenterol.. 2019. https://doi.org/10.1016/j.clinre.2019.05.003
Wang Q, Li YH, Lin GL et al. Primary hypertrophic osteoarthropathy related gastrointestinal complication has distinctive clinical and pathological characteristics: two cases report and review of the literature. Orphanet J Rare Dis. 2019;14:297. https://doi.org/10.1186/s13023-019-1264-5.
Singh A. Cryptogenic Multifocal Ulcerating Stenosing Enteropathy(CMUSE) and/or Chronic Non-specific Multiple Ulcers of the Small Intestine(CNSU) and Non-granulomatous Ulcerating Jejunoileitis (NGUJI). Curr Gastroenterol Rep. 2019;21:53. https://doi.org/10.1007/s11894-019-0721-6.
Richards S, Aziz N, Bale S et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424. https://doi.org/10.1038/gim.2015.30.
Huang H, Wang Y, Cao Y et al. Interleukin-6, tumor necrosis factor-alpha and receptor activator of nuclear factor kappa ligand are elevated in hypertrophic gastric mucosa of pachydermoperiostosis. Sci Rep. 2017;7:9686. https://doi.org/10.1038/s41598-017-09671-7.
Li SS, He JW, Fu WZ, Liu YJ, Hu YQ, Zhang ZL. Clinical, biochemical, and genetic features of 41 Han Chinese families with primary hypertrophic osteoarthropathy, and their therapeutic response to etoricoxib: results from a six-month prospective clinical intervention. J Bone Miner Res. 2017;32:1659–1666. https://doi.org/10.1002/jbmr.3157.
Oba MS, Murakami Y, Nishiwaki Y et al. Estimated prevalence of Cronkhite-Canada Syndrome, Chronic Enteropathy Associated with SLCO2A1 Gene, and Intestinal Behçet's Disease in Japan in 2017: a nationwide survey. J Epidemiol. 2020. https://doi.org/10.2188/jea.JE20190349.
Perlemuter G, Guillevin L, Legman P, Weiss L, Couturier D, Chaussade S. Cryptogenetic multifocal ulcerous stenosing enteritis: an atypical type of vasculitis or a disease mimicking vasculitis. Gastroenterology. 2001;48(3):333–338. https://doi.org/10.1136/gut.48.3.333.
Zhang Y, Huang L, Liu R et al. Case report of a pair of siblings with cryptogenic multifocal ulcerating stenosing enteritis: A rare disease easily to be misdiagnosed as Crohn disease. Medicine. 2017;96:e7527. https://doi.org/10.1097/md.0000000000007527.
Yanai S, Yamaguchi S, Nakamura S et al. Immunohistochemical distinction of chronic enteropathy associated with SLCO2A1 from Crohn's disease. Inflamm Bowel Dis. 2017;23:S63.
Yamaguchi S, Yanai S, Nakamura S et al. Immunohistochemistry differentiation between chronic enteropathy associated with SLCO2A1 and other inflammatory bowel diseases. J Gastroenterol hepatol. 2016;31:123.
Matsuno Y, Umeno J, Esaki M et al. Measurement of prostaglandin metabolites is useful in diagnosis of small bowel ulcerations. World journal of gastroenterology. 2019;25:1753–1763. https://doi.org/10.3748/wjg.v25.i14.1753.
Gomez I, Foudi N, Longrois D, Norel X. The role of prostaglandin E2 in human vascular inflammation. Prostaglandins Leukot Essent Fatty Acids. 2013;89:55–63. https://doi.org/10.1016/j.plefa.2013.04.004.
Omori K, Kida T, Hori M, Ozaki H, Murata T. Multiple roles of the PGE2 -EP receptor signal in vascular permeability. Br J Pharmacol. 2014;171:4879–4889. https://doi.org/10.1111/bph.12815.
Acknowledgments
We thank the patients and their families for participating in this study. We also thank Drs. Zhenlin Zhang and Yang Xu for measuring the urinary PGE2 and PGE-M levels of patients for us.
Funding
This study was supported by the National Natural Science Foundation of China (Grant No. 81741057).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval
This study was approved by the Ethics Committee of The Second Xiangya Hospital of Central South University and all methods were in accordance with the Declaration of Helsinki. All participants provided written informed consent forms to genetic and biochemical analysis and to publication of all identifying images.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Huang, H., Wang, X., Ou, D. et al. Four Variants of SLCO2A1 Identified in Three Chinese Patients with Chronic Enteropathy Associated with the SLCO2A1 Gene. Dig Dis Sci 66, 2992–3001 (2021). https://doi.org/10.1007/s10620-020-06629-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-020-06629-0